My impression is they don't make much money on COVID related sales.
See page 5 from their FY20 presentation:
"Management replaced much of the elective surgery lost revenue with new income streams (e.g. PPE sales). However gross margins were lower during the final quarter. The Company’s gross margin for FY20 was still a respectable 37.5% (FY19 40.3%) nonetheless."
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
0.005(1.23%) |
Mkt cap ! $678.6M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 41.0¢ | 39.5¢ | $209.5K | 518.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 368238 | 8 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PGC (ASX) Chart |